These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1995639

  • 41. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A.
    Nüsing RM, Barsig J.
    Br J Pharmacol; 1999 Jun; 127(4):919-26. PubMed ID: 10433499
    [Abstract] [Full Text] [Related]

  • 42. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
    Okabe-Kado J, Honma Y, Hayashi M, Hozumi M.
    Anticancer Res; 1991 Jun; 11(1):181-6. PubMed ID: 2018352
    [Abstract] [Full Text] [Related]

  • 43. Radioimmunoassay for activin A/EDF. Method and measurement of immunoreactive activin A/EDF levels in various biological materials.
    Shintani Y, Takada Y, Yamasaki R, Saito S.
    J Immunol Methods; 1991 Mar 21; 137(2):267-74. PubMed ID: 2013701
    [Abstract] [Full Text] [Related]

  • 44. Impaired erythroid-specific gene expression in cAMP-dependent protein kinase-deficient murine erythroleukemia cells.
    Pilz RB.
    J Biol Chem; 1993 Sep 25; 268(27):20252-8. PubMed ID: 8376386
    [Abstract] [Full Text] [Related]

  • 45. Activin A: a commitment factor in erythroid differentiation.
    Shiozaki M, Kosaka M, Eto Y.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):631-5. PubMed ID: 9464268
    [Abstract] [Full Text] [Related]

  • 46. Stimulation of FSH release by erythroid differentiation factor (EDF).
    Kitaoka M, Yamashita N, Eto Y, Shibai H, Ogata E.
    Biochem Biophys Res Commun; 1987 Aug 14; 146(3):1382-5. PubMed ID: 3113433
    [Abstract] [Full Text] [Related]

  • 47. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1.
    Eto Y, Tsuji T, Takezawa M, Takano S, Yokogawa Y, Shibai H.
    Biochem Biophys Res Commun; 1987 Feb 13; 142(3):1095-103. PubMed ID: 3470005
    [Abstract] [Full Text] [Related]

  • 48. Evidence that a novel human differentiation-inhibiting protein blocks the dimethyl sulfoxide-induced differentiation of erythroleukemia cells by inhibiting the activation of membrane protein kinase C.
    Durkin JP, Chakravarthy B, Tremblay R, Jouishomme H, Whitfield JF, Biquard JM, Krsmanovic V.
    Cancer Res; 1992 Nov 15; 52(22):6329-34. PubMed ID: 1423278
    [Abstract] [Full Text] [Related]

  • 49. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K, Mathur RS, Duzic E, Halushka PV.
    Am J Physiol; 1993 Dec 15; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [Abstract] [Full Text] [Related]

  • 50. The extracts from rat submandibular glands induce the erythroid differentiation of K-562 cells.
    Sasaki R, Masuyama A, Etoh Y, Yoshida H, Miura Y, Sasaki H.
    Leuk Res; 1995 Jun 15; 19(6):397-405. PubMed ID: 7596152
    [Abstract] [Full Text] [Related]

  • 51. Thromboxane A2 synthase activity in platelet free human monocytes.
    Orlandi M, Bartolini G, Belletti B, Spisni E, Tomasi V.
    Biochim Biophys Acta; 1994 Dec 08; 1215(3):285-90. PubMed ID: 7811713
    [Abstract] [Full Text] [Related]

  • 52. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells.
    Hyman T, Rothmann C, Heller A, Malik Z, Salzberg S.
    Exp Hematol; 2001 May 08; 29(5):563-71. PubMed ID: 11376868
    [Abstract] [Full Text] [Related]

  • 53. Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.
    Watanabe T, Kume T, Tsuneizumi K, Kondo K, Shiraishi T, Oishi M.
    Exp Cell Res; 1992 Apr 08; 199(2):269-74. PubMed ID: 1312008
    [Abstract] [Full Text] [Related]

  • 54. Identification of a specific receptor for erythroid differentiation factor on follicular granulosa cell.
    Sugino H, Nakamura T, Hasegawa Y, Miyamoto K, Igarashi M, Eto Y, Shibai H, Titani K.
    J Biol Chem; 1988 Oct 25; 263(30):15249-52. PubMed ID: 2844805
    [Abstract] [Full Text] [Related]

  • 55. mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl.
    Machida H, Ogawa K, Funaba M, Mizutani T, Tsujimoto M.
    Eur J Endocrinol; 2000 Nov 25; 143(5):705-10. PubMed ID: 11078996
    [Abstract] [Full Text] [Related]

  • 56. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells.
    Fibach E, Reuben RC, Rifkind RA, Marks PA.
    Cancer Res; 1977 Feb 25; 37(2):440-4. PubMed ID: 264411
    [Abstract] [Full Text] [Related]

  • 57. Dimethyl sulfoxide-inducible cytoplasmic factor involved in erythroid differentiation in mouse erythroleukemia (Friend) cells.
    Watanabe T, Oishi M.
    Proc Natl Acad Sci U S A; 1987 Sep 25; 84(18):6481-5. PubMed ID: 3476957
    [Abstract] [Full Text] [Related]

  • 58. The measurement of activin/EDF in mouse serum: evidence for extragonadal production.
    Sakai R, Shiozaki M, Tabuchi M, Eto Y.
    Biochem Biophys Res Commun; 1992 Oct 30; 188(2):921-6. PubMed ID: 1445333
    [Abstract] [Full Text] [Related]

  • 59. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec 30; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 60. NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activity.
    Francastel C, Poindessous-Jazat V, Augery-Bourget Y, Robert-Lézénès J.
    Leukemia; 1997 Feb 30; 11(2):273-80. PubMed ID: 9009092
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.